Retinoic acid and interferon α act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5551-5558

  Lingen, Mark W ^a,c   Polverini, Peter J ^b   Bouck, Noël P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; RECOMBINANT ALPHA INTERFERON AD; RETINOIC ACID;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CATTLE; CELL DIVISION; CELLS, CULTURED; CHEMOPREVENTION; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTERFERON TYPE I, RECOMBINANT; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032404102     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
2. Boring, C. C., Squire, T. S., Tong, T., and Montgomery, S. Cancer statistics. CA. Cancer J. Clin., 44: 7-26, 1994.
3. Lippman, S. M., and Hong, W. K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int. J. Radiat. Oncol. Biol. Phys., 17: 691-694, 1989.
4. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
5. Hong, K. W., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
6. Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., and Hong, K. W. Comparison of low-dose isotretinoin with β carotene to prevent oral carcinogenesis. N. Engl. J. Med., 328: 15-20, 1993.
7. Amos, B., and Lotan, R. Retinoid-sensitive cells and cell lines. Methods Enzymol., 190: 217-225, 1990.
8. Zou, C. P., Clifford, J., Xu, X. C., Sacks, P., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid of squamous differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
9. Shalinsky, D. R., Bischoff, E. D., Gregory, M. L., Gottardis, M. M., Hayes, J. S., Lamph, W. W., Heyman, R. A., Shirley, M. A., Cooke, T. A., Davies, P. J., and Thomazy, V. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Cancer Res., 55: 3183-3191, 1995.
10. Lotan, R., Lotan, D., and Sacks, P. G. Inhibition of tumor cell growth by retinoids. Methods Enzymol., 190: 100-110, 1990.
11. Sacks, P. G., Harris, D., and Chou, T. C. Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents. Int. J. Cancer, 61: 409-415, 1995.
12. Oikawa, T., Hirotani, K., Nakamura, O., Shudo, K., Hiragun, A., and Iwahuchi, T. A highly potent anti-angiogenic activity of retinoids. Cancer Lett., 48: 157-162, 1989.
13. Ingber, D., and Folkman, J. Inhibition of angiogenesis through modulation of collagen metabolism. Lab. Invest., 59: 44-51, 1989.
14. Arensman, R. M., and Stolar, C. H. Vitamin A effect on tumor angiogenesis. J. Pediatr. Surg., 14: 809-813, 1979.
15. Majewski, S., Szmurlo, A., Marczak, M., Jablonska, S., and Bollag, W. Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combinations. Cancer Lett., 75: 35-39, 1993.
16. Lingen, M. W., Polverini, P. J., and Bouck, N. P. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab. Invest., 74: 476-483, 1996.
17. Lingen, M. W., Polverini, P. J., and Bouck, N. P. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am. J. Pathol., 149: 247-258, 1996.
18. Borden, E. C. Interferons: expanding therapeutic roles. N. Engl. J. Med., 326; 1491-1493, 1992.
19. Brouty-Boye, D., and Zetter, B. R. Inhibition of cell motility by interferon. Science (Washington DC), 208: 516-518, 1980.
20. Sidky, Y., and Borden, E. Inhibition of angiogenesis by interferons: effects on tumor and lymphocyte-induced vascular responses. Cancer Res., 47: 5155-5161, 1987.
21. Friesel, R., Komoriya, A., and Maciag, T. Inhibition of endothelial cell proliferation by gamma-interferon. J. Cell Biol., 104: 689-696, 1987.
22. Maheshwari, R. K., Srikantan, V., Bhartiya, D., Kleinman, H. K., and Grant, D. S. Differential effects of interferon gamma and alpha on in vitro model of angiogenesis. J. Cell Physiol., 146: 164-169, 1990.
23. Ruszcak, Z., Detmar, M., Imcke, E., and Orfanos, C. E. Effects of rIFN alpha, beta and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cell in vitro. J. Invest. Dermatol., 95: 693-699, 1990.
24. Saiki, I., Sato, K., Yoo, Y. C., Murata, J., Yoneda, J., Kiso, M., Hasegawa, A., and Azuma, I. Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-γ followed by a synthetic lipid-A subunit analogue. Int. J. Cancer, 51: 641-645, 1992.
25. Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., and Fidler, I. J. Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 4562-4566, 1995.
26. Ezekowitz, R. A., Mulliken, J. B., and Folkman, J. Interferon α-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med., 326: 1456-1463, 1992.
27. Jones, G. J., and Itri, L. Safety and tolerance of recombinant interferon α-2a in cancer patients. Cancer (Phila.), 57: 1709-1715, 1986.
28. Lippman, S. M., Glisson, B. S., Kavanagh, J. J., Lotan, R., Hong, W. K., Paredes-Espinoza, M., Hittelman, W. N., Holdener, E. E., and Krakoff, I. H. Retinoic acid and interferon combination studies in human cancer. Eur. J. Cancer, 29A: 9-13, 1993.
29. Marth, C., Daxenbichler, G., and Dapunt, O. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J. Natl. Cancer Inst., 77: 1197-1202, 1986.
30. Lotan, R., Dawson, M. I., Zou, C. C., Jong, L., Lotan, D., and Zou, C. P. Enhanced efficacy of combinations of retinoic acid and retinoid X receptor selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
31. Kolla, V., Lindner, D. J., Weihua, X., Borden, E. C., and Kalvakolanu, D. V. Modulation of interferon-inducible gene expression by retinoic acid: upregulation of stat1 protein in IFN-unresponsive cells. J. Biol. Chem., 271: 10508-10514, 1996.
32. Lindner, D. J., Borden, E. C., and Kalvakolanu, D. V. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo. Clinical Cancer Res., 3: 931-937, 1997.
33. Toma, S., Monteghirfo, S., Tasso, P., Nicolo, G., Spadini, N., Palumbo, R., and Molina, F. Antiproliferative and synergistic effect of interferon α-2a, and retinoids and their association in established human cancer cell lines. Cancer Lett., 82: 209-216, 1994.
34. Frey, J., Peck, R., and Bollag, W. Antiproliferative effects of retinoids, cytokines and the combination in four human transformed epithelial cell lines. Cancer Lett., 62: 167-172, 1992.
35. Moore, D. M., Kalvakolanu, D. V., Lippman, S. M., Kavanagh, J. J., Hong, W. K., Borden, E. C., Paredes-Espinoza, M., and Krafoff, I. H. Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin. Hematol., 31: 31-37, 1994.
36. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol., 106: 761-771, 1988.
37. Rehberg, E., Kelder, B., Hoal, E. G., and Pestka, S. Specific molecular activities of recombinant and hybrid leukocyte interferons. J. Biol. Chem., 257: 11497-11502, 1982.
38. Clayman, G. L., El-Naggar, A. K., Zhang, W. W., Taylor, D. L., Roth, J. A., Goepfert, H., and Liu, T-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
39. Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCullouch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., and Dirix, L. Y. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer, 32A: 2474-2484, 1996.
40. Oliveira, I. C. Sciavolino, P. J., Lee, T. H., and Vilcek, J. Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. USA, 89: 9049-9053, 1992.
41. Oliveira, I. C., Mukaida, M., Matushima, K., and Vilcek, J. Transcriptional inhibition of the IL-8 gene by interferon is mediated by the NF-κB site. Mol. Cell. Biol., 14: 5300-5308, 1994.
42. Shiro, M., and Matsushima, K. Enhanced phosphorylation of 65 and 74 kDa proteins by tumor necrosis factor α and IL-1 in human peripheral blood monocytes. Cytokine, 2: 13-20, 1990.
43. Larsen, C. G., Kristensen, M., Paludan, K., Deleuran, B., Thomsen, M. K., Zachariae, K., Matsushima, K., and Thestrup-Pederson, K. Vitamin D3 is a potent regulator of IL-1 induced IL-8 expression and production. Biochem. Biophys. Res. Commun., 176: 1020-1026, 1991.
44. Standiford, T. J., Streiter, R. M., Chensue, S. W., Westwick, J., Kasahara, K., and Kunkel, S. L. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol., 145: 1435-1439, 1990.
45. Anttila, H. S., Reitamo, S., Ceska, M., and Hurme, M. Signal transduction pathways leading to the production of IL-8 by human monocytes are differentially regulated by dexamethasone. Clin. Exp. Immunol., 89: 509-512, 1992.
46. Brem, H., Gresser, I., Grosfeld, J., and Folkman, J. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J. Pediatr. Surg., 10: 1253-1257.
47. Parangi, S., O'Reilly, M., Christofori, G., Holmgrem, L., Grosfeld, J., Folkman, J., and Hanahan, D. Anti-angiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.
48. Bouck, N., Stellmach, V., and Hsu, S. How tumors become angiogenic. Adv. Cancer Res., 69: 135-174, 1996.
49. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
50. Hori, A., Sadada, R., Masutani, E., Naito, K., Sakura, Y., Fujita, T., and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human fibroblast growth factor. Cancer Res., 51: 6180-6184, 1991.
51. Kim, D. J., Li, B., Winer, J., Armanini, M., Gillet, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor cell growth in vivo. Nature (Lond.), 362: 841-844, 1993.
52. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullirich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-578, 1994.
53. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases-balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
54. O'Reilly, M. S., Holgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1995.
55. O'Reilly, M. S., Boehm, T., Sing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.